A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...

A U.S. federal judge in Texas on Thursday blocked a rule that expanded the amount of information companies have to turn over when seeking a merger review, saying it exceeded the Federal Trade ...

Please note that these calendars are subject to change without notice. If you have any questions or concerns, please contact the Office of the Registrar. For past Academic Calendars, please send an ...